Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: iloprost
Trade Name: Aurlumyn
Date Designated: 06/29/2022
Orphan Designation: Treatment of frostbite
Orphan Designation Status: Designated/Approved
Eicos Sciences, Inc.
122 2nd Ave.
Suite 200
San Mateo, California 94401
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: iloprost
Trade Name: Aurlumyn
Marketing Approval Date: 02/13/2024
Approved Labeled Indication: treatment of severe frostbite in adults to reduce the risk of digit amputations
Exclusivity End Date: 02/13/2031 
Exclusivity Protected Indication* :  treatment of severe frostbite in adults to reduce the risk of digit amputations
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-